CPHI China Pharma Holdings Inc.: רווחיות תפעולית

China Pharma Holdings (CPHI) is in its maturity stage, optimizing costs for 2026. Growth is driven by generics and demand across regional clinics in the PRC, although API procurement is outsourced, creating a dependency on suppliers. This chart on GURU.Markets reflects a shift in the operating margin level, where the parameter value equals -119.00, allowing for a correlation between actual profit and market demand.
China Pharma Holdings Inc. (CPHI) - פילוחי מדדים ודוחות פיננסיים

To objectively evaluate China Pharma Holdings (CPHI), analyzing the efficiency of pharmaceutical production and distribution is critical. The operating margin, as reflected by the operating margin changes on GURU.Markets, is calculated as the ratio of operating profit to revenue, showing the portion of net income derived from every yuan earned. The stability of this ratio confirms management's ability to maintain the profitability of the drug portfolio amid strict government price regulations.